LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5194 | 5505 | 0.9435 | 0.9191 |
BT-20 | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5262 | 5505 | 0.9557 | 0.9367 |
BT-20 | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5165 | 5505 | 0.9383 | 0.9116 |
BT-20 | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5763 | 5505 | 1.0469 | 1.0670 |
BT-20 | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 4955 | 5505 | 0.9001 | 0.8571 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP5 | 72 | hr | 1657 | 2032 | 5505 | 0.3691 | 0.0973 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 1657 | 2049 | 5505 | 0.3723 | 0.1019 |
BT-20 | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5029 | 5505 | 0.9135 | 0.8762 |
BT-20 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 4407 | 5505 | 0.8006 | 0.7147 |
BT-20 | Nilotinib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5401 | 5505 | 0.9810 | 0.9728 |
BT-20 | Nintedanib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5735 | 5505 | 1.0417 | 1.0596 |
BT-20 | NU7441 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5902 | 5505 | 1.0721 | 1.1032 |
BT-20 | Dactolisib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 2346 | 5505 | 0.4261 | 0.1789 |
BT-20 | NVP-TAE684 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 3725 | 5505 | 0.6767 | 0.5374 |
BT-20 | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 3420 | 5505 | 0.6212 | 0.4581 |
BT-20 | PD0325901 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5016 | 5505 | 0.9111 | 0.8728 |
BT-20 | PD0325901 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 4941 | 5505 | 0.8975 | 0.8533 |
BT-20 | PD173074 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5982 | 5505 | 1.0866 | 1.1239 |
BT-20 | PD184352 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5799 | 5505 | 1.0534 | 1.0764 |
BT-20 | Pelitinib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5301 | 5505 | 0.9630 | 0.9470 |
BT-20 | PF431396 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 4657 | 5505 | 0.8460 | 0.7796 |
BT-20 | PF477736 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5322 | 5505 | 0.9666 | 0.9523 |
BT-20 | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 4735 | 5505 | 0.8601 | 0.7999 |
BT-20 | PHA-665752 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5904 | 5505 | 1.0723 | 1.1035 |
BT-20 | PHA-793887 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 2954 | 5505 | 0.5367 | 0.3371 |